| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ISP13: Advanced glycation endproducts in food and medicine
|
Schalkwijk, C.G.
|
|
2012
|
38 |
S5 |
p. S92-
1 p.
|
artikel
|
| 2 |
ISP10: A model for predicting cardiovascular risk in patients with type 2 diabetes mellitus based on the ADVANCE study
|
Travert, F.
|
|
2012
|
38 |
S5 |
p. S91-S92
2 p.
|
artikel
|
| 3 |
ISP18: Artery stiffness and remodelling in diabetes and renal failure
|
Boutouyrie, P.
|
|
2012
|
38 |
S5 |
p. S94-
1 p.
|
artikel
|
| 4 |
ISP23: Aspirin efficacy in diabetes
|
Dillinger, J.G.
|
|
2012
|
38 |
S5 |
p. S96-
1 p.
|
artikel
|
| 5 |
ISP7: Care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome
|
Vergès, B.
|
|
2012
|
38 |
S5 |
p. S90-S91
2 p.
|
artikel
|
| 6 |
ISP25: Early left ventricular dysfunction in diabetes
|
Giorda, C.B.
|
|
2012
|
38 |
S5 |
p. S96-S97
2 p.
|
artikel
|
| 7 |
ISP16: Endothelial dysfunction in type 2 diabetes
|
Natali, A.
|
|
2012
|
38 |
S5 |
p. S93-S94
2 p.
|
artikel
|
| 8 |
ISP14: Exercise, sympatho-vagal balance and postprandial glucose profile
|
Chapelot, D.
|
|
2012
|
38 |
S5 |
p. S92-S93
2 p.
|
artikel
|
| 9 |
ISP15: Functional and morphological changes in the arterial wall in diabetes and aging. Role of AGEs
|
Grossin, N.
|
|
2012
|
38 |
S5 |
p. S93-
1 p.
|
artikel
|
| 10 |
ISP26: How molecular imaging may guide personalized cardiovascular risk assessment and care?
|
Rouzet, François
|
|
2012
|
38 |
S5 |
p. S97-
1 p.
|
artikel
|
| 11 |
ISP19: Impaired glucose tolerance and cardiovascular risk
|
Schnell, O.
|
|
2012
|
38 |
S5 |
p. S94-S95
2 p.
|
artikel
|
| 12 |
ISP1: Incretin therapy and cardiovascular risk
|
Marx, N.
|
|
2012
|
38 |
S5 |
p. S89-
1 p.
|
artikel
|
| 13 |
ISP4: Markers of cardiovascular disease in the sleep apnea syndrome
|
Möhlenkamp, S.
|
|
2012
|
38 |
S5 |
p. S90-
1 p.
|
artikel
|
| 14 |
ISP22: Metabolic determinants of cerebrovascular disease in type 2 diabetes
|
Lalic, N.
|
|
2012
|
38 |
S5 |
p. S95-S96
2 p.
|
artikel
|
| 15 |
ISP5: Metabolic disorders in the sleep apnea syndrome
|
Wilding, J.
|
|
2012
|
38 |
S5 |
p. S90-
1 p.
|
artikel
|
| 16 |
ISP17: Microvascular rarefaction in diabetes and hypertension
|
Lévy, B.I.
|
|
2012
|
38 |
S5 |
p. S94-
1 p.
|
artikel
|
| 17 |
ISP3: Myocardial Grafting and Diabetes
|
Menasché, P.
|
|
2012
|
38 |
S5 |
p. S89-
1 p.
|
artikel
|
| 18 |
ISP24: New oral anticoagulants
|
Apostolakis, S.
|
|
2012
|
38 |
S5 |
p. S96-
1 p.
|
artikel
|
| 19 |
ISP2: Non glycemic effects of DPP-4 inhibitors
|
Avogaro, A.
|
|
2012
|
38 |
S5 |
p. S89-
1 p.
|
artikel
|
| 20 |
ISP9: Not all fat is bad in cardiovascular risk. Mechanistic considerations about visceral versus femoral adipose tissues
|
Lafontan, M.
|
|
2012
|
38 |
S5 |
p. S91-
1 p.
|
artikel
|
| 21 |
ISP27: Omega 3 PUFA chain length: a key factor of their efficiency on cardiovascular risk factors in experimental metabolic syndrome
|
Grynberg, A.
|
|
2012
|
38 |
S5 |
p. S97-
1 p.
|
artikel
|
| 22 |
ISP12: Role of postprandial hyperglycemia and glycemic variability
|
Ceriello, A.
|
|
2012
|
38 |
S5 |
p. S92-
1 p.
|
artikel
|
| 23 |
ISP20: Should we still revascularize diabetic patients with coronary artery disease and how ?
|
Varenne, O.
|
|
2012
|
38 |
S5 |
p. S95-
1 p.
|
artikel
|
| 24 |
ISP6: Silent myocardial ischemia in diabetic patients
|
Cosson, E.
|
|
2012
|
38 |
S5 |
p. S90-
1 p.
|
artikel
|
| 25 |
ISP8: Targeting normoglycemia in dysglycaemia patients at high CV risks: what are the benefits and risks?”
|
Rydén, L.
|
|
2012
|
38 |
S5 |
p. S91-
1 p.
|
artikel
|
| 26 |
ISP11: What is behind the cardiovascular residual risk?
|
Valensi, Paul
|
|
2012
|
38 |
S5 |
p. S92-
1 p.
|
artikel
|
| 27 |
ISP21: Which antiaggregant strategy in diabetic patients with coronary artery disease?
|
Gilard, M.
|
|
2012
|
38 |
S5 |
p. S95-
1 p.
|
artikel
|
| 28 |
OP10: Analysis of the relationship between the presence of metabolic syndrome with the level of oxidized LDL and impaired fibrinolysis in patients with patients with type 2 diabetes
|
Singh, S.
|
|
2012
|
38 |
S5 |
p. S101-S102
2 p.
|
artikel
|
| 29 |
OP12: Association between retinopathy and early echographic markers of cardiomyopathy in type 2 diabetes
|
Decker-Bellaton, A.
|
|
2012
|
38 |
S5 |
p. S102-
1 p.
|
artikel
|
| 30 |
OP7: Chronic hyperglycemia induces GLP-1R resistance in terms of antioxidant and er stress response in HuVEC cells
|
Pujadas, G.
|
|
2012
|
38 |
S5 |
p. S100-S101
2 p.
|
artikel
|
| 31 |
OP9: Diet modulates endogenous thrombin generation, a biological estimate of thrombosis risk, independently of the metabolic status
|
Sanchez, C.
|
|
2012
|
38 |
S5 |
p. S101-
1 p.
|
artikel
|
| 32 |
OP8: Early atherosclerosis in Familial Partial Lipodystrophy of the Dunnigan-type: Endothelial cell dysfunction induced by p.R482W lamin-A
|
Bidault, G.
|
|
2012
|
38 |
S5 |
p. S101-
1 p.
|
artikel
|
| 33 |
OP6: Endothelium-independent vascular reactivity in high-fat diet-fed rats: role of vascular wall and perivascular adipose tissue oxidative stress
|
Achard, V.
|
|
2012
|
38 |
S5 |
p. S100-
1 p.
|
artikel
|
| 34 |
OP5: Low Cardiovascular (CV) Risk Hazard Ratio Observed with Linagliptin in Type 2 Diabetes: Further Insights from a Predefined CV Meta-Analysis
|
Johansen, O.E.
|
|
2012
|
38 |
S5 |
p. S99-S100
2 p.
|
artikel
|
| 35 |
OP11: Metabolic and vascular determinants of increased left ventricular torsion in patients with type 2 diabetes mellitus
|
Kuehl, M.
|
|
2012
|
38 |
S5 |
p. S102-
1 p.
|
artikel
|
| 36 |
OP4: Metformin decreases plasma levels of fibulin-1, a novel marker of arterial matrix alterations in diabetes
|
Rasmussen, L.M.
|
|
2012
|
38 |
S5 |
p. S99-
1 p.
|
artikel
|
| 37 |
OP3: Oxidized LDL as residual lipid risk marker in type 2 diabetes
|
Rajkovic, N.
|
|
2012
|
38 |
S5 |
p. S98-S99
2 p.
|
artikel
|
| 38 |
OP2: Presence of albuminuria can determine eligible subjects for the screening of coronary artery disease in patients with diabetes mellitus
|
Sanghoon, S.
|
|
2012
|
38 |
S5 |
p. S98-
1 p.
|
artikel
|
| 39 |
OP1: Risk predictors of cardio- and cerebrovascular hospital mortality in diabetic patients of the Munich Registries
|
Boenner, P.
|
|
2012
|
38 |
S5 |
p. S98-
1 p.
|
artikel
|
| 40 |
OP13: The effect of poly(ADP-ribose)polymerase inhibitors on diabetes-induced heart dysfunctions
|
Kuchmerovska, T.
|
|
2012
|
38 |
S5 |
p. S102-S103
2 p.
|
artikel
|
| 41 |
P 17: Analysis of the relationship between parameters of total and abdominal obesity, levels of lipoproteins and occurrence of coronary heart disease in type 2 diabetes
|
Stosic, L.
|
|
2012
|
38 |
S5 |
p. S110-
1 p.
|
artikel
|
| 42 |
P 4: Association of insulin sensitivity level and atherogenic lipid profile in mild cognitive impairment
|
Macesic, M.
|
|
2012
|
38 |
S5 |
p. S104-
1 p.
|
artikel
|
| 43 |
P 30: Cardiovascular risk factors in type 2 diabetes along 3 years of follow-up
|
Arrieta, F.
|
|
2012
|
38 |
S5 |
p. S115-
1 p.
|
artikel
|
| 44 |
P 13: Chemokine receptor antagonists influence on monocytes infiltration through endothelial cells monolayer studied by a real-time electrical impedance assay
|
Stan, D.
|
|
2012
|
38 |
S5 |
p. S108-
1 p.
|
artikel
|
| 45 |
P 12: Chronic and oscillating high glucose induce, through oxidative stress, A “memory” effect for endoglin and NRF-2-downstream genes in endothelial cells
|
La Sala, L.
|
|
2012
|
38 |
S5 |
p. S108-
1 p.
|
artikel
|
| 46 |
P 21: Clinical and metabolic correlates of diastolic dysfunction in patients with type 2 diabetes
|
Seferovic Mitrovic, J.P.
|
|
2012
|
38 |
S5 |
p. S111-S112
2 p.
|
artikel
|
| 47 |
P 20: Coronary microvascular response to a coldpressor test and cardiac autonomic neuropathy in asymptomatic type 2 diabetic patients free of coronary stenoses
|
Nguyen, M.T.
|
|
2012
|
38 |
S5 |
p. S111-
1 p.
|
artikel
|
| 48 |
P 2: CRP as a possible predictor for peripheral arterial disease in patients with type 2 diabetes
|
Popovic, Lj.
|
|
2012
|
38 |
S5 |
p. S103-S104
2 p.
|
artikel
|
| 49 |
P 1: Do adiponectin levels explain the atherogenic properties of Hp 2-2 phenotype in type 2 diabetic patients?
|
Frand, J.
|
|
2012
|
38 |
S5 |
p. S103-
1 p.
|
artikel
|
| 50 |
P 7: Does choice of antidiabetic and/or antihypertensive treatment influence progression of nephropathy in hypertensive type 2 diabetic patients?
|
Jelic, S.
|
|
2012
|
38 |
S5 |
p. S105-S106
2 p.
|
artikel
|
| 51 |
P 25: Effect of metformin on arterial properties, adiponectin, leptin and glucose homeostasis in patients with nonalcoholic fatty liver disease
|
Borislavsky, A.
|
|
2012
|
38 |
S5 |
p. S113-
1 p.
|
artikel
|
| 52 |
P 10: Enhancement of antioxidant defence against oxidative stress by timolol-treatment prevents age-/diabetes-related cardiac dysfunction via recovery of intracellular Ca2+ handling
|
Turan, B.
|
|
2012
|
38 |
S5 |
p. S107-
1 p.
|
artikel
|
| 53 |
P 14: Hypertriglyceridemic waist phenotype in type 2 diabetes: association with higher hs-CRP and lower antioxidative enzyme activity
|
Draskovic Radojkovic, D.
|
|
2012
|
38 |
S5 |
p. S109-
1 p.
|
artikel
|
| 54 |
P 27: Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine/CX3CR1 expression by TLR4 and Gi proteins pathways
|
Gan, A.M.
|
|
2012
|
38 |
S5 |
p. S114-
1 p.
|
artikel
|
| 55 |
P 29: Insulinotropic constituents and evaluation of ethnomedical claim of gongronema latifolium root and stem
|
Adebajo, A.C.
|
|
2012
|
38 |
S5 |
p. S115-
1 p.
|
artikel
|
| 56 |
P 3: Insulin sensitivity and related atherogenic conditions in ischemic stroke: comparison between type 2 diabetics and nondiabetics
|
Milicic, T.
|
|
2012
|
38 |
S5 |
p. S104-
1 p.
|
artikel
|
| 57 |
P 15: Low serum levels of L-Selectin as markers of silent myocardial ischemia and endothelial dysfunction in type 2 diabetic patients
|
Cosson, E.
|
|
2012
|
38 |
S5 |
p. S109-
1 p.
|
artikel
|
| 58 |
P 6: Markers of systemic inflammation and ApoAI-containing HDL subpopulations in women with and without diabetes
|
Russo, G.T.
|
|
2012
|
38 |
S5 |
p. S105-
1 p.
|
artikel
|
| 59 |
P 31: Medication intensification strategies and outcomes in patients with type 2 diabetes (T2DM) who have A1C ≥ %7 on ≤ 2 oral anti-diabetes agents (OAD)
|
Korytkowski, M.
|
|
2012
|
38 |
S5 |
p. S115-S116
2 p.
|
artikel
|
| 60 |
P 26: Metabolic effects of simvastatin and Omega-3 polyunsaturated fatty acids in type 2 diabetic patients with cardiovascular autonomic neuropathy
|
Serhiyenko, V.A.
|
|
2012
|
38 |
S5 |
p. S113-S114
2 p.
|
artikel
|
| 61 |
P 24: Non alcoholic fatty liver disease in type 2 diabetes patients
|
Idzior-Walus, B.
|
|
2012
|
38 |
S5 |
p. S113-
1 p.
|
artikel
|
| 62 |
P 19: Obesity: Modeling the effect on human biomass and the impact on type 2 Diabetes
|
Boutayeb, A.
|
|
2012
|
38 |
S5 |
p. S111-
1 p.
|
artikel
|
| 63 |
P 22: Omega-3 polyunsaturated fatty acids alleviates heart pump function in Type I diabetic cardiomyopathy
|
Zhukovska, A.
|
|
2012
|
38 |
S5 |
p. S112-
1 p.
|
artikel
|
| 64 |
P 8: Peripheral insulin resistance influence the presence of hypertension in overweight type 2 diabetic patients
|
Lukic, L.
|
|
2012
|
38 |
S5 |
p. S106-
1 p.
|
artikel
|
| 65 |
Programme
|
|
|
2012
|
38 |
S5 |
p. S87-S88
2 p.
|
artikel
|
| 66 |
P 11: Role of herbal extracts in the prevention of oxidative stress and modulation of atherogenic risk factors in experimentally-induced DM
|
El-Missiry, M.A.
|
|
2012
|
38 |
S5 |
p. S107-S108
2 p.
|
artikel
|
| 67 |
P 16: Role of short-term and advanced glycation end products in arterial stiffness in diabetes and prediabetes
|
Fysekidis, M.
|
|
2012
|
38 |
S5 |
p. S109-S110
2 p.
|
artikel
|
| 68 |
P 28: Some contributions to the evaluation of ethnomedical antidiabetic claims of African medicinal plants
|
Adebajo, A.C.
|
|
2012
|
38 |
S5 |
p. S114-S115
2 p.
|
artikel
|
| 69 |
P 9: Taurine protects against impairment of mitochondrial function and oxidative stress in the heart of rats with fructose-induced insulin resistance
|
Gorbenko, N.
|
|
2012
|
38 |
S5 |
p. S106-S107
2 p.
|
artikel
|
| 70 |
P 23: The possible contribution of thyroid hormones to insulin effect on beta adrenoceptor mediated cardiac responses in diabetic rats
|
Arioglu-Inan, E.
|
|
2012
|
38 |
S5 |
p. S112-S113
2 p.
|
artikel
|
| 71 |
P 18: The prevalence of multivessels coronary stenosis in patients with diabetes mellitus
|
Mankovsky, G.
|
|
2012
|
38 |
S5 |
p. S110-
1 p.
|
artikel
|
| 72 |
P 5: Value of the UKPDS risk score in the screening of asymptomatic type 2 diabetic patients for coronary stenoses and artery stiffness
|
Belhadj-Mostefa, Azzedine
|
|
2012
|
38 |
S5 |
p. S105-
1 p.
|
artikel
|
| 73 |
Welcome to the 5th Annual Meeting of the Diabetes & Cardiovascular Disease
|
|
|
2012
|
38 |
S5 |
p. S85-
1 p.
|
artikel
|
Tijdschrift beschrijving